Actrapid and Graft versus host disease - a phase IV clinical study of FDA data

Summary:

Graft versus host disease is reported as a side effect among people who take Actrapid (insulin), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Vancomycin, and have Nausea.

The phase IV clinical study analyzes which people have Graft versus host disease when taking Actrapid. It is created by eHealthMe based on reports of 4,843 people who have side effects when taking Actrapid from the FDA, and is updated regularly.

What is Actrapid?

Actrapid has active ingredients of insulin. eHealthMe is studying from 4,864 Actrapid users. Check the latest studies of Actrapid.

What is Graft versus host disease?

Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body) is found to be associated with 498 drugs and 642 conditions by eHealthMe. Check the latest studies of Graft versus host disease.

On Jul, 04, 2026

4,843 people reported to have side effects when taking Actrapid.
Among them, 24 people (0.5%) have Graft versus host disease.

Could Actrapid cause Graft versus host disease?

Among these 24 people:

How long have people been on Actrapid when they have Graft versus host disease? *

What is the gender of people who have Graft versus host disease when taking Actrapid? *

female: 21.74 %
male: 78.26 %

What is the age of people who have Graft versus host disease when taking Actrapid? *

What are other drugs people take besides Actrapid? *

What are other side effects people have besides Graft versus host disease? *

Erythema Multiforme (a type of hypersensitivity reaction): 20 people, 83.33%
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 7 people, 29.17%
Epidermal Necrolysis (skin condition that is usually caused by a reaction to drugs): 6 people, 25.00%
Rash Erythematous (redness of the skin): 6 people, 25.00%
Fever: 5 people, 20.83%
Rash Macular (small, flat red spots): 4 people, 16.67%
Cardiac Failure: 3 people, 12.50%
Pneumonia: 3 people, 12.50%
C-Reactive Protein Increased: 3 people, 12.50%
Multi-Organ Failure (multisystem organ failure): 3 people, 12.50%

What are the existing conditions these people have? *

Urinary Tract Infection: 16 people, 66.67%
Hypotension (abnormally low blood pressure): 16 people, 66.67%
Bleeding Disorders: 16 people, 66.67%
Conjunctivitis (pink eye): 16 people, 66.67%
Depression: 16 people, 66.67%
Fungal Infection: 16 people, 66.67%
Sedation: 16 people, 66.67%
Hyperkalemia (damage to or disease of the kidney): 16 people, 66.67%
Infection: 16 people, 66.67%
Nausea (feeling of having an urge to vomit): 16 people, 66.67%

* Approximation only. Some reports may have incomplete information.

Do you take Actrapid and have Graft versus host disease?

- Check whether Graft versus host disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Actrapid:

Actrapid (4,864 reports)

Browse all side effects of Actrapid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Graft versus host disease:

Graft versus host disease (498 drugs)

Browse all the conditions that are associated with Graft versus host disease:

Graft versus host disease (642 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin (the active ingredients of Actrapid) and Actrapid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.